Sargent Investment Group’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-12,732
Closed -$66.1K 252
2024
Q3
$66.1K Sell
12,732
-115
-0.9% -$597 0.01% 209
2024
Q2
$33K Sell
12,847
-48
-0.4% -$123 0.01% 217
2024
Q1
$63.4K Sell
12,895
-927
-7% -$4.56K 0.01% 195
2023
Q4
$121K Buy
+13,822
New +$121K 0.03% 202